https://www.has-sante.fr/jcms/p_3576148/fr/sam-de-l-ansm-sur-la-carbamazepine-modification-des-conditions-de-prescription-et-de-delivrance-cpd-pour-les-patientes-afin-de-reduire-les-risques-malformatifs-lies-a-l-exposition-in-utero 2025 France evaluation of the transparency committee professional practice congenital abnormalities prescription, nos pharmaceutical preparations operations research indexing macrophage activation syndrome carbamazepine risk tool, nos Exhibition decision support techniques meconium aspiration syndrome patients uterus, nos carbamazepine has patient mosaic variegated aneuploidy syndrome delivery, obstetric developmental anomaly, nos drug, nos effects of exposure to external cause, nos Abstracting and Indexing